Scripps Clinical Advances in Heart Failure, Arrhythmias and Cardiogenic Shock Symposium 2025
Shop with confidence
Scripps Clinical Advances in Heart Failure, Cardiogenic Shock & Pulmonary Hypertension 2025
Advanced Evidence‑Based Management of Complex Cardiovascular Disease
One‑time access · Lifetime availability · Google Drive delivery
Conference Overview
The Scripps Clinical Advances in Heart Failure, Cardiogenic Shock and Pulmonary Hypertension Symposium 2025 is designed to equip clinicians with the latest diagnostic strategies, therapeutic approaches, and multidisciplinary care models for advanced cardiovascular disease. The program emphasizes translation of scientific evidence into real‑world practice to improve outcomes across heart failure, cardiogenic shock, cardiomyopathies, arrhythmias, and pulmonary hypertension.
Educational Objectives
- Apply current and emerging evidence in complex cardiovascular disease management.
- Implement guideline‑directed medical therapy (GDMT) algorithms in heart failure.
- Compare pharmacologic and device‑based therapies for cardiogenic shock.
- Recognize racial and gender disparities in cardiac device selection.
- Diagnose and manage cardiac amyloidosis and pulmonary hypertension.
- Adopt interdisciplinary care strategies across the cardiovascular continuum.
Who Should Attend
- Cardiologists and heart failure specialists
- Electrophysiologists and arrhythmia specialists
- Critical care and ICU physicians
- Cardiac surgeons and transplant teams
- Advanced practice providers, nurses, residents, and fellows
What You’ll Learn
- Modern pharmacologic and device therapies for HFrEF and HFpEF
- Advanced cardiogenic shock management (Impella, ECMO, LVAD)
- Arrhythmia ablation, device implantation, and guideline updates
- Cardiac amyloidosis, cardiomyopathies, and advanced imaging
- Comprehensive pulmonary hypertension diagnosis and treatment
Scientific Program Highlights
Two‑day agenda covering GDMT optimization, cardiogenic shock escalation strategies, pulmonary embolism and PERT teams, HFpEF and obesity, amyloidosis, hypertrophic cardiomyopathy, myocarditis, pulmonary hypertension, arrhythmias, and cardiorenal syndromes through expert lectures and interactive panels.
Agenda, faculty, and times subject to change.
Related Cardiology Courses
| Course | Best For | Rating |
|---|---|---|
| Mayo Clinic Interventional Cardiology Online Board Review 2025 | Interventional cardiology boards | ★★★★★ |
| Scripps 14th Annual Structural Heart Intervention & Imaging 2025 | Structural heart disease | ★★★★★ |
| The Pass Machine Cardiology QBank | Board exam preparation | ★★★★★ |
| Cardiology Board & Certification Review 2025 (PDF) | Comprehensive review | ★★★★☆ |
| Mayo Clinic 2025 Electrophysiology Online Board Review | EP specialists | ★★★★★ |
| Advanced Echocardiography 2025 | Advanced echo users | ★★★★☆ |
| Mayo Clinic Cardiovascular Online Board Review 2025 | General cardiology boards | ★★★★★ |
| BoardVitals Cardiology & Echocardiography QBank 2025 | Practice questions | ★★★★★ |
| Harvard Update in Clinical Cardiology 2025 | Clinical updates | ★★★★★ |
| ASNC 2025 Nuclear Cardiology Board Exam Prep | Nuclear cardiology | ★★★★☆ |
| Mayo Clinic Echocardiography Online Board Review 2025 | Echo boards | ★★★★★ |
FAQ
All materials are delivered via Google Drive with lifetime, unlimited access.
Yes. The symposium focuses on complex heart failure, shock, arrhythmias, and pulmonary hypertension.
Yes. Content aligns with contemporary ACC/AHA and international guideline recommendations.
